Miguel Quijada-Álamo

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

J. Hernández-Rivas, A. Kohlmann, Mónica Sala-Valdés, 2017, British Journal of Cancer.